HAB Pharmaceuticals
Brain & Nerve Care1X10 Tablet
Prescription required
This medicine is dispensed only against a valid prescription from a registered medical practitioner. You’ll be asked to upload it at checkout, and a pharmacist reviews it before dispatch.
Prescription policyYou save ₹256.00 · Inclusive of all taxes
CITISIGN P tablet by HAB Pharmaceuticals — each tablet contains Citicoline 500 mg and Piracetam 400 mg; available in strip packing from India.
Available on order. The seller arranges supply before dispatch.
CITISIGN P is a tablet formulation produced by HAB Pharmaceuticals. The supplied composition is Citicoline 500 mg plus Piracetam 400 mg per tablet. It is supplied in strip packing and classified under Brain & Nerve Care. This product listing provides only the formulation and basic product details supplied by the vendor. For guidance on whether this medicine is appropriate for you, how to take it, or any safety information, refer to the manufacturer’s label or speak with your doctor or pharmacist.
CITISIGN P is a medicine manufactured by HAB Pharmaceuticals. Each tablet contains Citicoline 500 mg and Piracetam 400 mg. The product is supplied in strip packing and is listed under the Brain & Nerve Care category. Country of origin: India. This summary presents only the vendor-supplied product facts (brand, composition, form and packing). It does not provide prescribing, dosing, safety or clinical indications. For full and authoritative information including approved uses, dosage, contraindications and safety data, consult the printed product label, the patient leaflet, your prescribing doctor, or a pharmacist.
The vendor facts for CITISIGN P do not include approved medical uses or indications. For information on what conditions this medicine is licensed to treat, discuss with your prescribing doctor or review the printed product leaflet and label supplied with the medicine. Healthcare professionals can provide the appropriate clinical context and determine whether this product is suitable for your specific health needs.
The vendor-supplied product details list only the composition and packaging of CITISIGN P (Citicoline 500 mg + Piracetam 400 mg). They do not include claims about therapeutic benefits or approved indications. For information on the approved benefits, clinical use, or expected effects of this medicine, consult the product leaflet, your prescribing physician, or a pharmacist. Do not base treatment decisions on this product summary alone.
Each tablet contains: Citicoline 500 mg + Piracetam 400 mg.
Specific instructions on how to use CITISIGN P are not provided in the vendor facts. Consult the printed product label, the patient information leaflet, your prescribing doctor, or a pharmacist for the manufacturer’s recommended administration, timing relative to meals, and any other usage instructions. Do not rely on this summary for dosing or administration guidance; follow professional medical advice and the directions on the packaging.
This product summary contains only vendor-supplied facts about composition and packaging. Before using CITISIGN P, consult the printed product label, your prescribing physician, or a pharmacist for safety guidance. Inform healthcare professionals about any allergies, current medications (including over-the-counter and herbal products), medical conditions, pregnancy or breastfeeding. Do not share prescription medicines with others. Keep the medicine out of reach of children and store and dispose of it according to the manufacturer’s instructions. Side effect information for CITISIGN P is not provided in the vendor facts. Refer to the printed product leaflet or speak with your prescribing doctor or pharmacist for a complete list of possible adverse effects, common and rare. If you experience any unexpected or severe symptoms while taking this medicine, seek medical advice promptly. Do not rely on this listing for safety information; always consult the manufacturer’s documentation or a healthcare professional.
Specific warnings and contraindications for CITISIGN P are not included in the vendor information. Consult the product leaflet, your prescribing physician, or a pharmacist for warnings related to allergies, medical conditions, pregnancy, breastfeeding, driving or operating machinery, and other precautions. Only a healthcare professional can evaluate risks for individual patients. Information on drug interactions for CITISIGN P is not provided in the supplied product facts. Before starting this medicine, inform your doctor or pharmacist about all prescription drugs, over-the-counter medicines, herbal remedies, and supplements you are taking so a professional can check for potential interactions. Do not combine medications without medical advice.
The vendor facts do not include storage instructions for CITISIGN P. Check the product carton and leaflet for the manufacturer’s specific storage recommendations (temperature, humidity, and light exposure). As a general precaution, keep tablets in their original strip until use, retain packaging for batch and expiry information, store out of reach of children and pets, and consult a pharmacist for safe disposal of expired or unused medicine.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
CITISIGN P is listed as a medicine. Use it only as directed by a registered medical practitioner.
Yes. It is dispensed only against a valid prescription from a registered medical practitioner, which you upload at checkout.
The vendor facts do not include storage instructions for CITISIGN P. Check the product carton and leaflet for the manufacturer’s specific storage recommendations (temperature, humidity, and light exposure). As a general precaution, keep tablets in their original strip until use, retain packaging for batch and expiry information, store out of reach of children and pets, and consult a pharmacist for safe disposal of expired or unused medicine.